Friday, April 5, 2013
What do you see as the major factors involved in the controversy with the use of selective serotonin reputable inhibitors (SSRIs) used to treat adolescent depression?
Selective serotonin reputable inhibitors (SSRIs) are a group of chemically unequaled antidepressant drugs. SSRIs work by blocking a receptor in the brain, which absorbs the chemical serotonin, which influences mood ("WebMD", 2013). SSRIs controlled research is limited for the treatment of children. With limited controlled research it is rather difficult to determine if SSRI treatments for children and adolescents is appropriate, and the length of timeframe SSRIs should be used for therapy. Although, some research does show when using SSRIs children and adolescents show an increase of suicidal thoughts, some mild side effects, and frequent side effects, such as vomiting, headaches, tremors, and insomnia. Other side effects include sleep disturbances, mania or hypomania, motor restlessness, psychosis, and social disinhibition. The major factors involved in the controversy with the use of SSRIs are limited controlled research and side effects. As clinical practices continue experiments with the use of SSRIs therapies, a more comprehensive understanding will develop as for the role of these drugs for children and adolescent depression treatments. The FDA has only approved one SSRI for the treatment of depression in children and adolescents ages 8 to 17, which is ofluoxetine (Prozac) and for adolescents 12 and over the FDA has approved the usage of escitalopram (Lexapro).
WebMD. (2013). Retrieved from http://www.webmd.com/depression/ssris-myths-and-facts-about-antidepressants